Yes, you read that right. The Pfizer trial for age 6 months to 4 years failed even its nonclinical endpoint with a small two dose regimen. A three dose trial is underway.
No worries for the FDA, which invited Pfizer to file for an Emergency Use Authorization anyway, on the apparent theory that we should give small children – at near zero risk of a severe COVID outcome – two useless doses now essentially on the come, just for a head start in case the three dose trial data is favorable.
Wow, imagine if a Trump administration asked Pfizer to submit data for vaccine approval when 2 doses failed the very low bar of non-inferiority and 3 doses was ongoing.https://t.co/f8sHHSlpei
— Vinay Prasad, MD MPH 🎙️📷 (@VPrasadMDMPH) February 1, 2022
We are horrified by this decision. Why is the FDA paying billions of dollars to pharmaceutical companies to develop and disseminate a vaccine a vaccine for infants when there are close to zero benefits, but unknown risks to their health? The FDA recently granted emergency vaccine authorization for ages 5 to 11 while stressing repeatedly that it was a close call and justified only because of rare high risk children. We worry that the militant left will soon be endorsing vaccine mandates for ALL newborns and toddlers.